Hsp90, a dimeric ATP-dependent molecular chaperone, is required for the folding and activation of numerous essential substrate ''client'' proteins including nuclear receptors, cell cycle kinases, and telomerase. Fundamental to its mechanism is an ensemble of dramatically different conformational states that result from nucleotide binding and hydrolysis and distinct sets of interdomain interactions. Previous structural and biochemical work identified a conserved arginine residue (R380 in yeast) in the Hsp90 middle domain (MD) that is required for wild type hydrolysis activity in yeast, and hence proposed to be a catalytic residue. As part of our investigations on the origins of species-specific differences in Hsp90 conformational dynamics we probed the role of this MD arginine in bacterial, yeast, and human Hsp90s using a combination of structural and functional approaches. While the R380A mutation compromised ATPase activity in all three homologs, the impact on ATPase activity was both variable and much more modest (2-7 fold) than the mutation of an active site glutamate (40 fold) known to be required for hydrolysis. Single particle electron microscopy and small-angle X-ray scattering revealed that, for all Hsp90s, mutation of this arginine abrogated the ability to form the closed ''ATP'' conformational state in response to AMPPNP binding. Taken together with previous mutagenesis data exploring intraand intermonomer interactions, these new data suggest that R380 does not directly participate in the hydrolysis reaction as a catalytic residue, but instead acts as an ATP-sensor to stabilize an NTD-MD conformation required for efficient ATP hydrolysis.
Introduction
Hsp90 is a member of the molecular chaperone family of proteins that facilitate protein folding in the cell. Well-characterized chaperones including Hsp60 (GroEL/ES) and Hsp70 (DnaK) promote protein folding by discrete cycles of ATP hydrolysis-driven binding and release of nascent polypeptides and exposed hydrophobic regions. 1 However, unlike those family members, Hsp90 acts much later in the folding process, interacting with a specific set of client proteins in a near-native state conformation and promoting conformational rearrangements required for ligand binding and downstream signaling events. [2] [3] [4] [5] [6] [7] In eukaryotes, these client proteins include many signaling and regulatory proteins such as serine/threonine and tyrosine kinases, telomerase, steroid hormone receptors, and tumor suppressor proteins. [8] [9] [10] [11] The importance of these client proteins in signaling and cellular function has made Hsp90 an attractive target for anticancer therapeutics. 12 A majority of the drugs that inhibit Hsp90 function target the ATP binding pocket underscoring the importance of ATP hydrolysis in its chaperoning activity. 13, 14 Although nucleotide hydrolysis has been shown to be absolutely required for the in vivo chaperone function of Hsp90 15, 16 how the energy from ATP binding and hydrolysis contributes to both chaperone conformational changes and client activation remains largely unknown.
Hsp90 is a constitutive dimer where each $90 kDa monomer consists of three domains: the N-terminal nucleotide-binding domain (NTD), the middle domain (MD), and the C-terminal dimerization domain (CTD). Hsp90 domain structures, [17] [18] [19] comparisons with other GHKL superfamily members such as MutL and GyrB, 17, [19] [20] [21] and Hsp90 truncation studies concluded that the Hsp90 NTD provides all of the structural requirements for nucleotide binding 5, 17, 22 and a conserved catalytic glutamate which activates the attacking water in the ATP hydrolysis reaction 23 [ Fig. 1(c) ]. However, the NTD alone is not sufficient for ATP hydrolysis, the MD is required for even minimal activity and full activity requires both the MD and dimerization. 5 The availability of full-length crystal structures of the bacterial (apo and ADP states) 24 and yeast Hsp90 (using the nonhydrolyzable ATP analog, AMPPNP) 25 provided important insights into the relationships between domain structure, organization, and ATPase activity. The structures revealed dramatically different conformational states that are stabilized by different interactions, each with varying degree of exposure of conserved hydrophobic patches on the chaperone, in response to nucleotide binding [ Fig. 1(a) ], 24, 25 suggesting an allosteric coupling between nucleotide and conformational states. Single particle EM studies confirmed that these three conformational states (apo, ATP, ADP) are uni-versally conserved across bacterial, yeast, and human Hsp90s. 26 By contrast, analysis of individual Hsp90 molecules by EM and population averages by SAXS revealed that AMPPNP or ADP binding does not trigger a discrete conformational change but rather shifts a preexisting equilibrium of states toward the appropriate conformation. [26] [27] [28] Kinetic studies on Hsp90 homologs from different species demonstrated that the chaperone is a very slow ATPase with activities ranging from 0.1 (human) to 1.2 (yeast) pmol/min/pmol 18, 19 although this can be altered by client binding. [29] [30] [31] Data from yeast mutants suggests that ATPase rates are precisely tuned for each organism, as even small increases or decreases in ATPase rates (T22I 7-fold increase; T101I 3-fold decrease) will compromise growth ability. 16 From enzyme kinetics, it appears that the chemical ATP hydrolysis step is orders of magnitude faster than domain closure, indicating that conformational changes are rate-limiting. 32 This is supported by an observed cross-species correlation between ATPase rates and the population of closed states in the presence of AMPPNP 26 as well as by direct kinetic observation of domain closure by either FRET or small angle x-ray scattering (SAXS). 27, 28 Given the apparent contradiction between the required precision of ATPase rates for in vivo function and the rather weak coupling between nucleotide and conformation observed in vitro, we wished to further probe the molecular basis for nucleotide recognition, hydrolysis, and chaperone conformation.
Initially identified by comparison with GHKL family members, [33] [34] [35] arginine 380 in the yeast Hsp82 MD (referred to as Arg MD to simplify cross species comparisons), was shown to have a significant role in ATP hydrolysis (related to Lys 307 of MutL and Lys 33 of GyrB). Mutation of this residue in Hsp90 resulted in a decrease in ATP hydrolysis in vitro and a loss of viability in vivo, 19 leading to the suggestion that Arg MD is a catalytic residue directly participating in the activation and chemistry of the hydrolysis reaction. The crystal structure of Hsp82 in complex with AMPPNP and the co-chaperone Sba1 supported this hypothesis, revealing a direct interaction between the Arg MD and the AMPPNP c-phosphate in the closed state [ Fig.  1 (c)]. 25 By contrast, the E. coli apo N-M structure, Grp94 N-M structures, and the yeast MD structures (PDB: 1Y4U, 2O1W, 1HK7) all show a direct interaction of Arg MD with an exposed and conserved loop on the MD stabilizing the apo state of Hsp90 [ Fig. 1 
Previous work from our lab indicated that Arg MD does not act alone in the activation of ATP hydrolysis but rather is involved synergistically with a network of residues from both monomers to stabilize a hydrolysis competent Hsp90 conformation. 36 While investigating this network of interactions we discovered that the equivalent Arg to Ala mutation in E. coli (R336A) had an unexpectedly mild affect raising questions about the true role of this important residue, and indicating that further investigation was required.
Results

Hydrolysis rates of the middle domain arginine indicate a noncatalytic role in ATP hydrolysis
Arg MD was mutated to an alanine in the bacterial (HtpGR336A), yeast (Hsc82R376A), and human (Hsp90aR400A) Hsp90 homologs and ATP hydroly-sis rates were measured by release of radioactive inorganic phosphate. Previous work has shown that the affinity of ATP for the NTD alone is essentially unchanged when compared to the full-length protein (132 lM vs. 172 lM, respectively), thus residues in the MD, including the Arg MD , do not contribute significantly to nucleotide binding. 15, 17 The Hsp90-specific inhibitor, geldanamycin, was used to control for any small amounts of contaminating ATPases (see Methods). Mutation of Arg MD resulted in a decreased ATPase rate in all species, with yeast showing the most severe effect (a seven-fold reduction) ( Fig. 2 ; Table I ). By contrast, the human and bacterial Hsp90s, showed only marginal (approximately two-fold) losses in activity when compared to their respective wild-type constructs. Given the very high levels of sequence and structural conservation, this was quite unexpected, although these results are comparable to those observed for mutations of the homologous residue in MutL, Lys 307. 33 To ensure that we were mutating the homologous Arg MD between species we mutated and measured the ATP hydrolysis rates of several positively charged residues surrounding Arg MD in the bacterial homolog. These mutations displayed no change in ATP hydrolysis (data not shown) when compared to the wild-type rate indicating that the originally mutated residues were indeed functionally homologous equivalents to Arg336 in yeast. Thus while Arg MD is important for maintaining wild-type levels of ATPase activity and yeast viability, the very mild affects observed in both the human and bacterial enzymes indicate that this residue is not essential for the ATPase reaction.
As a control for species/variant differences, we measured the ATP hydrolysis rates of the bacterial and yeast homologs with the known catalytic glutamate mutated to an alanine (Hsc82E33A and HtpGE34A); due to the very low ATPase basal activity of human Hsp90 and the known conserved catalytic role the respective catalytic glutamate mutation was not made. As expected, the bacterial and yeast mutants were both severely compromised (17-and 40-fold reductions, respectively) with almost no ATP hydrolysis measured above the noise level of this experiment ( Fig. 2 ; Table I ). These data support the known conserved role of the glutamate in the GHKL family of enzymes coordinating the attacking water in the hydrolysis reaction. 15, 21, 23, [33] [34] [35] Thus, with such a large discrepancy between the hydrolysis rates of the arginine and the glutamate mutations observed with both homologs and the overall modest loss in activity of the Arg MD mutants, our results suggest that the Arg MD is not required for catalysis, but instead plays an indirect role in promoting ATP hydrolysis.
Solution X-ray scattering suggests Arg MD is important for conformational stabilization
We next sought to better define the role of Arg MD . From crystal structures it is clear that the arginine residue adopts distinct local interactions in the apo and ATP states [ Fig. 1 (b,c)] that appears to stabilize Hsp90 into one conformation or the other. Given the unique arrangement of Arg MD in the closed state, an alternative role could be to stabilize a hydrolysiscompetent Hsp90 conformation in an ATP-specific manner. To test this, we performed small angle Xray scattering (SAXS) on the bacterial and yeast wild type and mutant constructs in the presence and absence of AMPPNP. Previous fluorescence studies have shown that the nonhydrolyzable analog of ATP, AMPPNP, is able to stabilize the same conformation of Hsp90 as ATP and is utilized in these structural studies to prevent conformational cycling of Hsp90. 28, 32 Experimental scattering intensity curves (I(q)) of each homolog were measured in the presence and absence of nucleotide and transformed into interatomic probability profiles, P(r), providing information on the overall molecular shape ( Fig. 3 ; left column). In both wild-type homologs, the apo state shows a broad distribution of distances in the P(r) curves representing the very extended open conformation populated in the absence of nucleotide. 27 With the addition of saturating amounts of AMPPNP the bacterial and yeast SAXS curves exhibit a more narrow range of distances in their P(r) curves with a peak around 55 Å indicating a Figure 2 . ATP hydrolysis rates of the bacterial, yeast, and human Hsp90 homologs. Bacterial, yeast, and human homologs of Hsp90 were mutated and assayed for ATP hydrolysis. Wild type rates are shown in black; arginine mutant rates are shown in gray; catalytic glutamate mutants are shown in white. All measured hydrolysis rates were normalized to the wild type yeast homolog rate. The Arg MD shows a substantial defect in ATP hydrolysis that was not consistent among all three homologs tested and was not as deleterious to activity as the catalytic glutamate in all three cases. more closed compact state of Hsp90. Beyond providing qualitative shape information, the P(r) profiles can be quantitatively fit to accurately determine Hsp90 conformations or to extract the relative populations of different conformational states. 27 In the absence of nucleotide, the P(r) curves are essentially identical for the E. coli, yeast, and Arg MD mutants ( Fig. 3; right column) . However, upon nucleotide addition neither mutant displayed the conformational shift observed in the wild-type proteins indicating that the closed state is not being formed in solution. Because the conformational equilibrium of wild-type human Hsp90 vastly favors the open state under saturating AMPPNP, 26 it was not productive to pursue SAXS measurements for the human arginine mutant ( Fig. 3 ; bottom row).
Electron microscopy confirms the middle domain arginine stabilizes the closed state of Hsp90
In support of the solution X-ray scattering data and to surmount the challenges in evaluating the effects of the Arg MD to Ala mutation on the human Hsp90, we used single particle negative stain electron microscopy 37 of the wild-type and mutant arginine in all three Hsp90 homologs in the presence and absence of the nonhydrolyzable ATP analog, AMPPNP. In the absence of nucleotide, the bacterial, yeast, and human homologs show a wide range of open angles between the two monomers similar to what was observed in our previous electron microscopy and SAXS studies ( Fig. 4 , Supporting Information Fig. 1 ). 26, 27 As observed previously, 26 upon the addition of AMPPNP the majority of the bacterial and yeast Hsp90s form the closed state with the NTDs dimerized in a conformation equivalent to that seen in the Hsp82:Sba1:AMPPNP crystal structure. 25 While HtpGR336A and Hsc82R376A looked identical to the wild-type under apo condi-tions (data not shown), no conversion to the closed state was observed upon the addition of 5 mM AMPPNP.
As seen with the human Hsp90 solution scattering results, the closed state is only transiently sampled despite the presence of saturating amounts of AMPPNP. Therefore, to address this, we added a small amount of glutaraldehyde crosslinker, as previously reported, 26 to trap the closed state in a nucleotide-dependent manner for visualization ( Fig. 4, Supporting Information Fig. 2 ). Following crosslinking, the closed state was not readily observed for human Hsp90aR400A in the presence of AMPPNP, while the wild type particles appeared closed and similar to HtpG and yeast under the same conditions. Thus, while the affects of this mutation on ATPase rates are modest and variable, our EM and SAXS results indicate a conserved and significant effect on closed conformation of Hsp90.
The middle domain arginine affects N-M domain dynamics
While mutation of Arg MD to an alanine blocks the ability to efficiently form the closed, NTD-dimerized state, it was unclear if Arg MD could directly stabilize an ATP hydrolysis competent NTD-MD conformation, or rather acted along only in the context of synergistic intersubunit interactions 36 that together support the closed NTD-dimerized state. To test this, we explored the Arg MD -Ala mutation in the context of a yeast Hsp90 construct lacking the CTD dimerization domain (Hsc82N599). In vitro, Hsc82N599 is a monomer in solution and shows an $10-fold reduction in ATP hydrolysis (Fig. 5 ) agreeing with data published previously for Hsp82. 5 As expected from the full-length results, when the catalytic glutamate was mutated to alanine in the truncated construct no activity could be measured. Upon mutation of Arg MD , ATPase activity decreased three-fold indicating that this arginine helps to stabilize a hydrolysis-competent NTD-MD conformation even in the absence of NTD dimerization. Notably, the activity of the Ala mutant in the fulllength protein is greater than the wild type N599 construct suggesting transient N-terminal dimeriza-tion and ATP hydrolysis in the full-length protein must be occurring even though it is below the detection threshold of our structural assays. This is supported by the contribution of cross-monomer residues to ATP hydrolysis, even in the context of the Arg MD mutant. 36 Discussion ATP hydrolysis and the conformational changes that are coupled to this catalytic cycle are central to the function of Hsp90 by providing the energy to bind, remodel, and release substrate client proteins. Although structural studies have shown that all homologs of Hsp90 appear to undergo similar conformational changes in the presence of nucleotide, there are substantial species-dependent differences in the conformational equilibria and kinetics. Mutations made in yeast Hsp82 that either subtly enhance or decrease ATP hydrolysis showed substantial growth defects indicating that ATPase rates and the conformational equilibrium are highly optimized for the specific function of each homolog in vivo. 16 To better understand how conformational equilibria and ATP hydrolysis are coupled and to determine if there is a universal mechanism among Hsp90 homologs despite the notable differences, we explored the role of the completely conserved Arg MD in the bacterial, yeast, and human Hsp90 homologs. As shown here, the large impact of mutating Arg MD to Ala on ATPase rate previously observed for yeast Hsp90, appears to be exclusive to yeast, with only two fold decreases observed with either the bacterial or human enzymes. This mild and variable contribution of Arg MD to ATP hydrolysis rates suggests that it does not make a critical contribution to chemical hydrolysis as expected for a conserved catalytic residue.
By contrast, electron microscopy and SAXS both indicated that Arg MD does play a conserved role in stabilizing the closed state in the presence of AMPPNP. Additionally, mutation of Arg MD has a significant affect on the ATPase activity of a monomeric yeast NTD-MD construct lacking the C-terminal dimerization domain. Together these data indicate that Arg MD must contribute directly to stabilization of a catalysis-competent NTD-MD conformation, independent of NTD dimerization. The importance of setting of a defined NTD-MD conformation is underscored by the recent discovery that a novel class of inhibitors that bind at this interface show both selectivity for nucleotide state and function by only inhibiting the binding of specific subsets of client and cochaperone interactions. 38, 39 While attention has focused on interaction of Arg MD with the c-phosphate of ATP, several apo Hsp90 crystal structures reveal that Arg MD directly interacts with a conserved MD loop in the apo Figure 5 . Middle domain arginine is directly involved in stabilizing an N-middle conformation that is competent for hydrolysis. Normalized ATPase activities of the yeast Hsp90 homolog, C-terminal truncation (N599), and the arginine and glutamate mutants in the C-terminal truncation construct. There is a substantial loss of activity observed when Cterminal dimerization is removed. A further loss of activity is seen when the arginine is mutated indicating its role in stabilizing a hydrolysis competent conformation of the Nmiddle domains. The glutamate mutant in the N599 construct shows no detectable activity as predicted from the full length activities.
state. 19, 40, 41 Thus some of the functional importance of Arg MD may come from its ability to also stabilize the apo conformation. From this structural data and the work presented here we propose a model where these stabilizing MD interactions in the apo state ( Fig. 6 ; yellow region) must first be released followed by a $90 degree rotation of the N-M domain 42 in order for NTD dimerization and subsequently ATP hydrolysis to occur. We propose that release of these constraints and sampling the N-M rotated conformation may actually represent the rate limiting steps in the ATP hydrolysis cycle ( Fig.  6 ; step 2) whereas ATP binding, NTD closure and chemical hydrolysis are comparatively fast. 32 Thus Arg MD may be playing a role in slowing the forward reaction by stabilizing the apo state while even more significantly slowing the rate of NTD rotation and re-opening by recognizing the ATP cphosphate. From current and previous work 36 we know that the closed and catalytically active conformation is synergistically stabilized by a combination of the Arg interactions, a cross-monomer hydrophobic interaction network, and the NTD dimerization interface.
Together this work shows that although Arg MD directly interacts with the c-phosphate, its primary role is as an ATP sensor that acts to stabilize a specific NTD-MD conformation rather than playing a direct catalytic role in the hydrolysis reaction. We also show that this mechanism of action is universal among a broad array of Hsp90 homologs even though ATP hydrolysis rates and conformational equilibria of the individual species vary greatly. In conjunction with previous work, 36 it is now apparent that the ATPase active conformation is stabilized by an array of interdomain and intersubunit interactions that include, but are not limited to NTD dimerization that ultimately act to tune the rates of to match the in vivo requirements for chaperone function.
Materials and Methods
Hsp90 homolog purification
All three proteins were purified in a similar manner. Bacterial and yeast protein was purified from induced E. coli cultures using Ni-NTA affinity resin (Qiagen), followed by anion exchange and size exclusion chromatography on a Superdex S200 column (GE Healthcare). Human Hsp90 was first purified from induced E. coli cultures using a DEAE column prior to the Ni-NTA affinity purification and gel filtration on S200. Protein was concentrated in 10 mM Tris pH 7.5, 100 mM NaCl using Ultrafree Biomax concentrators (Millipore) to a final concentration of 1-5 mg mL À1 based on UV 280 absorption. Protein was flash frozen in liquid nitrogen and stored at À80 C until use.
ATPase activity
This assay was adapted from Felts et al. 43 2uM protein was used in each assay with 1 mM ATP and 0.8 pM [ 32 Pc]ATP (6000 Ci mmol À1 ) in solution. For the assays using geldanamycin as a control, a final concentration of 200 lM was used. Twenty minute time points were taken over the course of an hour with the samples shaking and incubating at 37 C. Separation of P i from ATP was performed using the thin layer chromatography method described. 43 Visualization of the radiolabeled spots was performed on a Typhoon Imager (GE Healthcare) and quantification was performed using the program ImageQuant (GE Healthcare). The amount of ATP hydrolyzed at each time point was calculated by taking the ratio of P i to ATP in solution. This ratio was then multiplied by the total amount of ATP added to the reaction and normalized by the total protein in solution. A linear fit of the time points gave the rate for each reaction. Activity was plotted on bar graphs using the average of at least three measurements; error bars indicate the standard error of the mean.
SAXS data collection and data analysis
Data reported here was collected at the Advanced Light Source (ALS) beamline 12.3.1 and the Stanford Synchrotron Radiation Laboratory (SSRL) beamline 4.2. To minimize aggregation, samples were spun in a table-top microcentrifuge for 5 min before data collection. SAXS data was collected at 25 C at 2-5 mg mL À1 . At the ALS, the samples were exposed for 6 and 60 s at a detector distance of 1.6 m. At SSRL samples were exposed for ten 30-s exposures at a detector distance of 2.5 m. Scattering data was recorded on a Mar165CCD detector. The detector channels were converted to Q ¼ 4psiny/k, where 2y is the scattering angle and k is the wavelength, using a silver behenate sample as a calibration standard. The data was circularly averaged over the detector and normalized by the incident beam intensity. The raw scattering data were scaled and the buffers were subtracted. Individual scattering curves were then merged to provide the final averaged scattering curve. The interatomic distance distribution functions (P(r)) were then calculated using the program GNOM. 44 D max was determined by constraining r min to equal zero and then varying r max between 150 and 250 Å . R max was then chosen so that the P(r) curve smoothly approached zero at the upper limit. Small changes in r max (610 Å ) did not affect the overall shape of the P(r) curve. Radii of gyration were calculated from the P(r). Comparable results were obtained from the scattering curves using the Guinier approximation as implemented in the program PRIMUS, 44 however the calculated uncertainties were larger due to limitations in the low angle data.
Negative-stain electron microscopy
Purified Hsp90 protein was negatively stained with uranyl formate (pH 5.5-6.0) on thin carbon-layered (40-50 Å thick) 400 mesh copper grids (Pelco) as described. 45 Before staining, protein samples were incubated for 20 min at 150 nM with or without 5 mM AMPPNP (Sigma-Aldrich) at 37 C for E. coli and human Hsp90 and 30 C for yeast Hsp90 in 20 mM Tris (pH 7.5), 50 mM KCl, 5 mM MgCl 2 , and 1 mM DTT. Glutaraldehyde (0.005%) crosslinking was performed as described (Southworth and Agard, 2008) . Samples were imaged using a Tecnai G2 Spirit TEMs (FEI) operated at 120 keV. Micrograph images were recorded using a 4 k Â 4 k CCD camera (Gatan) at 68,000Â magnification with 2.2 Å pixel size.
